REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/21/2026
Back to search
Official data from USPTO
IMMUNE-ONC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/22/2026
Trademark type
Word
Nice classes
42
Filing date
09/06/2016
Registration date
02/21/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/14/2023
Last transaction
02/22/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
07/29/2016
First use in commerce
07/29/2016
Drawing code
4
Owner type
03
Owner location
Palo Alto, CA, US
Examiner
SNABB, SANDRA MARIE
Law office
N20
Current location
TMO LAW OFFICE 120
Holders and representatives
Holders
Immune-Onc Therapeutics, Inc.
Representatives
Yi Zhang
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Basic and clinical research in the field of respiratory science and medicine; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products
Publications
History of USPTO decisions and trademark events.
25 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/14/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/14/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/11/2023
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
07/31/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/31/2023
ES8R
TEAS SECTION 8 RECEIVED
02/20/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/28/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/21/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/17/2017
ALIE
ASSIGNED TO LIE
01/05/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/21/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
12/20/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/20/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
12/20/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/20/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2016
GNRT
NON-FINAL ACTION E-MAILED
12/15/2016
CNRT
NON-FINAL ACTION WRITTEN
12/15/2016
DOCK
ASSIGNED TO EXAMINER
12/13/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2016
NWAP
NEW APPLICATION ENTERED
09/09/2016
Continuous trademark protection
Get notified about every new filing that threatens IMMUNE-ONC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.